Padeniya sredi lits pozhilogo i starcheskogo vozrasta - I.V. Damulin 25 Ostrye i persistiruyushchie diarei u detey


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article discusses the problem of acute and persistent diarrhea in children. The major pathogenetic mechanisms of diarrhea syndrome in children, and the clinical features of diarrhea of various origins are considered. The data on the role of the drug Enterol in the prevention and treatment of diarrhea in children are presented.

Full Text

Restricted Access

References

  1. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57.
  2. Preliminary FoodNet Data on the Incidence of Foodborne Illnesses - Selected Sites, United States, 2002, MMWR Mortal Wkly Re 2003;52:340-43.
  3. Буланова И.А. и др. Этиологическая структура вирусных диарей у детей в Архангельской области // Инфекционные болезни 2008. Т. 6. № 1. С. 55-8.
  4. Turck D. Prevention and treatment of acute diarrhea in infants. Arch Pediatr 2007;14(11):1375-78.
  5. Simonovic I, Rosenberg J, Koutsouris A, Hecht G: Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions. Cell Microbiol 2000;2:305-15.
  6. Scott KG, Meddings JB and Kirik DR, et al. Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin light chain kinase-dependent fashion. Gastroenterol 2002;123:1179-90.
  7. Walsh SV, Hopkins AM, Chen J, et al. Rho kinase regulates tight junction function and is necessary for tight junction assembly in polarized intestinal epithelia. Gastroenterol 2001;121:566-79.
  8. Tafazoli F, Zeng CQ and Estes MK, et al. NSP4 enterotoxin of rotavirus induces paracellular leakage in polarized epithelial cells. J Virol 2001;75:1540-46.
  9. Fasano A, Fiorentini C and Donelli G, et al. Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. J Clin Invest 1995;96:710-20.
  10. Parashar U.D. et al. Global Illness and Deaths Caused by Rotavirus Disease in Children. Emerg Infect Dis 2003;9(5):565-72.
  11. Профилактика острых кишечных инфекций Электронный ресурс. 2008. Режим доступа: http://www.gsensao. ru/oki htm
  12. Ramani S, et al. Viruses causing childhood diarrhoea in the developing world. Curr Opin Infect Dis 2009;22(5):477-82.
  13. Teunis PF, et al. Norwalk virus: how infectious is it? Med Virol 2008;80(8):1468-76.
  14. Weber R. Protozoa: intestinal coccidia and microsporidia. In: Armstrong D, Cohen J, eds. Infectious diseases. London, 1999:32.1-32.8.
  15. Dupont H, Chapell C, Sterling C. The infectivity of Cryptosporidium parvum in healthy volonteers. N Engl J Med 1995;332:855-59. Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis 1992;15:573-81.
  16. Schumann A, Nutten S, Donnicola D, et al. Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome. Physiol Genomics 2005;23(2):235-45.
  17. Wilson CL, Ouellette AJ, Satchell DP, et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999;286(5437): 113-17.
  18. Viscidi R, Willey S, Bartlett JG. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 1981;81(1):5-9.
  19. Barbut F, Petit JC. Epidemiology of Clostridium difficile nosocomial infections. Presse Med 1996;25(8):385-92.
  20. Pituch H, Obuch-Woszczatynski P, Meisel-Mikolajczyk F, Luczak M. Prevalence of enterotoxygenic Bacteroides fragilis strains (ETBF) in the gut of children with clinical diagnosis of antibiotic associated diarrhea (AAD). Med Dosw Mikrobiol 2002;54(4):357-63.
  21. Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006;101: 1581-90.
  22. Ringel-Kulka T, Ringel Y. Probiotics in irritable bowel syndrome: Has the time arrived? Gastroenterology 2007;13 (2) 813-16.
  23. Cetina-Sauri G, Sierra Basto G. Therapeutic evaluation of Saccharomyces boulardii in children with acute diarrhea. Annales de Pediatrie 1994;41(6):397-400.
  24. Castaneda C, Garcia E, Santa Cruz M, et al. Effects of Saccharomyces boulardii in children with chronic diarrhea, especially cases due to giardiasis. Revista Mexicana de Puericultura y Pediatria 1995;2:12.
  25. Gedek BR. Adherence of E.coli serogroup O-157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 1999;42(4):261-64.
  26. Buts JP, Bernasconi P, Van Craymest MP, et al. Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii. Pediatric Research 1986;20:192-96.
  27. Cherucka D, Dahan S, Mograbi B, et al. Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infection and Immunity 2000;68:5998-6004.
  28. Kotowska M, Albrecht P, Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2005; 21(5):583-90.
  29. Thomas S, Metzke D, Schmitz J, et al. Antiinflammatory effects of Saccharomyces boulardii mediated by myeloid dendritic cells from patients withCrohn's disease and ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 301:G1083-G1092, 2011.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies